Renaissance Technologies’s Mural Oncology MURA Stock Holding History

Renaissance Technologies’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-146,000	Closed	-$302K	–	3572
2025 Q3	$302K	Buy	146,000 +134,200	+1,137%	+$288K	﹤0.01%	2992
2025 Q2	$29.1K	Buy	+11,800	New	+$27.8K	﹤0.01%	3447
2025 Q1	–	Sell	-238,465	Closed	-$768K	–	3710
2024 Q4	$768K	Buy	238,465 +35,403	+17%	+$125K	﹤0.01%	2627
2024 Q3	$636K	Sell	203,062 -29,038	-13%	-$94.6K	﹤0.01%	2673
2024 Q2	$729K	Buy	232,100 +15,100	+7%	+$55.7K	﹤0.01%	2498
2024 Q1	$1.06M	Buy	+217,000	New	+$1.05M	﹤0.01%	2446

Renaissance Technologies's MURA Position: Q4 2025 in Review

Renaissance Technologies sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 146,000 shares — an estimated $302K sold.

Renaissance Technologies first reported a position in MURA in Q1 2024 and held it in 6 quarters. The position peaked at $1.06M in Q1 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Renaissance Technologies reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Renaissance Technologies sold 146,000 Mural Oncology shares in Q4 2025, an estimated $302K.
Renaissance Technologies first reported a position in Mural Oncology in Q1 2024 and held it in 6 quarters.
Renaissance Technologies's Mural Oncology position peaked at $1.06M in Q1 2024.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.